Maria Vernera
banner
marianveneral.bsky.social
Maria Vernera
@marianveneral.bsky.social
Living life one adventure at a time
📍Los angeles, California
📍Project Europa/Middle East
@BioTech
A tiny white-petalled weed beloved of plant biologists has received a CRISPR-fueled makeover, turning it into a supersized ruby-colored bloom www.nature.com/articles/s41...
www.nature.com
September 27, 2025 at 8:34 AM
Chronic silencing is a critical barrier to breaking the cycle of bullying in academia and industry
go.nature.com/482BUOY
Chronic silencing is a critical barrier to breaking the cycle of bullying in academia and industry - Nature Biotechnology
Breaking the cycle of institutional betrayal and the culture of silence requires decisive actions to promote transparency, accountability and supportive environments in both academia and industry.
go.nature.com
September 25, 2025 at 8:37 PM
The long-anticipated move, criticised by the US and Israel, will see the three Commonwealth countries join France and several others in formally recognising a Palestinian state at the UN General Assembly this week. www.ft.com/content/36dd...
Client Challenge
Please enable JavaScript to proceed.
www.ft.com
September 21, 2025 at 3:26 PM
The September issue is live nature.com/nbt/volumes/...

On the cover, a system for high-precision mutation detection of mRNA in extracellular vesicles. Song et al. present SCOPE, a method that uses Cas13 to recognize and amplify target RNA for liquid biopsy applications go.nature.com/47Yw8Mf
Nature Biotechnology
Nature Biotechnology is a monthly journal publishing new concepts in biological technology of relevance to bioengineering, medicine, energy, agriculture, food ...
nature.com
September 17, 2025 at 9:01 AM
Bioactive molecules unearthed by terabase-scale long-read sequencing of a soil metagenome go.nature.com/4606ozA
Bioactive molecules unearthed by terabase-scale long-read sequencing of a soil metagenome - Nature Biotechnology
Optimized long-read sequencing constructs megabase-scale genome assemblies from complex soil samples.
go.nature.com
September 13, 2025 at 8:19 AM
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2 go.nature.com/4mTBGhr
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2 - Nature Biotechnology
A screen for protein degraders discovers hits by imaging cell survival.
go.nature.com
September 11, 2025 at 8:15 AM
Our answers to climate change are damaging nature on.ft.com/3JWL9Gf
Our answers to climate change are damaging nature
As the extinction of plants and animals accelerates, our dependence on the natural world is deepening
on.ft.com
September 10, 2025 at 12:17 PM
Quiet evening at Milan Cathedral, taking a short walk..
haha.. sorry that's my little friend from the Laboratory!!!
#milan
#Cathedral
September 7, 2025 at 9:14 PM
Nothing like sipping coffee while leveling up the brows multitasking at its finest... glam and calm in one moment.
#BrowGoals #GlamTime #BeautyRoutine
September 7, 2025 at 9:34 AM
Reposted by Maria Vernera
"In IRL events, there's a hell of a lot more accountability, and people behave very differently in person than they do virtually," founder Lucy Rout said.
This 30-year-old founder was so fatigued by dating apps, she started hosting IRL events: ‘I got to dating burnout’
"In IRL events, there's a hell of a lot more accountability, and people behave very differently in person than they do virtually," founder Lucy Rout said.
cnb.cx
August 31, 2025 at 2:00 AM
Reposted by Maria Vernera
Recent moves of note in and around the biotech and pharma industries go.nature.com/45WFeZc
rdcu.be/eCTpZ
People - Nature Biotechnology
Recent moves of note in and around the biotech and pharma industries.
go.nature.com
August 28, 2025 at 10:53 PM
Reposted by Maria Vernera
Employers can register for free, and must do so by Friday, September 5 at 3pm ET. For more information or to sign up, visit: docs.google.com/forms/d/e/1F...
NYU Center for Data Science Fall 2025 Career Fair: Employer Interest
Dear Employer Partners, The NYU Center for Data Science (CDS) Fall 2025 Career Fair will take place on Thursday, September 25, 2025 from 1:30PM-4:30PM ET in our open space at 60 Fifth Avenue and is ...
docs.google.com
August 21, 2025 at 7:37 PM
Reposted by Maria Vernera
CDS Assistant Professor Grace Lindsay (@neurograce.bsky.social) offers practical summer prep advice for incoming students: brush up on quantitative basics if you're targeting technical skills, or research industry job requirements and work backward to plan your academic path.
August 20, 2025 at 7:23 PM
Reposted by Maria Vernera
Australian startup Uluu is using seaweed and salt-loving microorganisms to produce bioplastics www.nature.com/articles/s41...
Ocean-grown bioplastics - Nature Biotechnology
Nature Biotechnology - Ocean-grown bioplastics
www.nature.com
August 4, 2025 at 3:09 PM
Reposted by Maria Vernera
Each year, we highlight companies that received sizeable early-stage funding in the previous year. @seaporttx.bsky.social is modifying central nervous system drugs for delivery through the lymphatic system, bypassing first-pass liver metabolism
Editor’s Pick: Seaport Therapeutics - Nature Biotechnology
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Seaport Therapeutics is modifying central nervous system drugs for delivery throug...
go.nature.com
August 4, 2025 at 1:40 PM
Reposted by Maria Vernera
🧬 A new AI tool from @utaustin.bsky.social & Sanofi could speed the development of mRNA-based therapies for viruses, cancers and genetic disorders. RiboNN predicts which mRNA sequences will be most efficiently translated into proteins. cns.utexas.edu/news/researc... @taccutexas.bsky.social
New AI Tool Accelerates mRNA-Based Treatments for Viruses, Cancers, Genetic Disorders
UT Austin and Sanofi partner to build tool that predicts translation efficiency of mRNA sequences.
cns.utexas.edu
July 25, 2025 at 4:03 PM
Reposted by Maria Vernera
At the intersection of biopharma and the public sector sits an extensive international community of non-profit R&D organizations steering life science innovations in the direction of global health burdens www.nature.com/articles/s41...
rdcu.be/eyzXy
Non-profits wade in where for-profit life science investment fears to tread - Nature Biotechnology
For decades, and in the exceptional instance of the Institut Pasteur for over a century, non-profit organizations have augmented R&D to advance scientific understanding and develop affordable and ...
www.nature.com
July 30, 2025 at 8:37 PM
Reposted by Maria Vernera
A λ exonuclease system exhibits protospacer-adjacent motif-independent DNA-binding specificity, enabling diagnostic and imaging applications go.nature.com/3TwgkKk
rdcu.be/eynve
Bacteriophage λ exonuclease and a 5′-phosphorylated DNA guide allow PAM-independent targeting of double-stranded nucleic acids - Nature Biotechnology
A λ exonuclease system exhibits protospacer-adjacent motif-independent DNA-binding specificity, enabling diagnostic and imaging applications.
go.nature.com
July 30, 2025 at 2:10 AM
Reposted by Maria Vernera
Admiral Michael Mullen, former chairman of the Joint Chiefs of Staff, once called the national debt the “greatest threat to national security.”

Watch CNBC's "America's Deficit Reckoning" to learn how the U.S. debt spiral could spark a crisis: cnb.cx/407S3O9
July 7, 2025 at 8:16 PM
Reposted by Maria Vernera
The greenback tumbled 10.7% against its global peers through June, making it the worst first half since 1973, back when Nixon broke the Bretton Woods gold standard. At its bottom, the currency hit its lowest point since February 2022.
The declining dollar faces more headwinds after posting worst first-half return in 52 years
The U.S. dollar faces a variety of headwinds heading into the second half of the year that could have important investing implications.
cnb.cx
July 7, 2025 at 8:00 PM
Reposted by Maria Vernera
IBM has been a hot stock, and CNBC’s Jim Cramer said CEO Arvind Krishna is to thank for Big Blue finding its mojo once again.
Jim Cramer salutes the CEO of an old-school tech stock that's making a lot of people money
CNBC's Jim Cramer on Monday marveled at the stock performance of IBM under CEO Arvind Krishna.
cnb.cx
July 7, 2025 at 7:40 PM
Reposted by Maria Vernera
Out in @natbiotech.nature.com: Metagenome taxonomy profilers usually ignore unknown species. SingleM is an accurate profiler which doesn't, even detecting phyla with no MAGs. Profiles of 700,000 metagenomes at sandpiper.qut.edu.au. A 🧵
July 16, 2025 at 9:59 PM
Reposted by Maria Vernera
Out today in @natbiotech.nature.com, IGI's @urnov.bsky.social and leaders across the #biotech industry on expanding patient access to #CRISPR cures with platform technology.
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable go.nature.com/4kCD1Y3
July 16, 2025 at 4:42 PM
Reposted by Maria Vernera
The Trump administration is rapidly unraveling federal support for scientific and technology research–terminating grants, capping funding, and tying awards to political criteria.

District courts are pushing back, writes @patentscholar.bsky.social, but consequences for US innovation are profound.
The Trump Administration’s Multi-Front Assault on Federal Research Funding
Costs for scientific progress and the public could be profound if the Trump administration succeeds in significantly cutting research funding.
www.justsecurity.org
July 9, 2025 at 1:22 PM